PUBLIC RECORD · 001
LAST REVIEWED
2026-08-30
Lipitor
Atorvastatin
ARCHIVE MARKETU.S. public record
INITIAL APPROVAL1996-12-17
DOSAGE-FORM CLASSOral solid dosage form
REVIEW STATUSPrimary source linked
ORIGIN · EVIDENCE · RECORD
What medicine is in your hand?
Start with the brand or generic name, then compare the market, dosage form, strength and official label. OriginDrug now publishes 286 source-traceable dossiers and connects 26,955 official product-source rows, helping you take a clearer question back to the exact pack, pharmacist and clinician.
DRUG FINDER
Start with a medicine name
The directory contains 286 source-traceable records, each with a primary-source reading route.
Common searches
You can enter the name printed on the pack, a generic name, a reviewed market name, or a reviewed presentation clue. A matching name only starts the record check: compare market, dosage form, stated strength and document date before drawing a conclusion.
Only matching records are shown. Clear the search and choose “All” to browse the complete directory.
286published source-traceable dossiers
26,955imported official product-source rows
400ordinary medicine-safety questions
SOURCE-TRACEABLE ARCHIVES
Records that start with the original document
Mental health · SOURCE-TRACEABLE
BuSpar
buspirone hydrochloride
Read the public record in its stated market, date and dosage-form context.
Read the archive and sources →Gastrointestinal · SOURCE-TRACEABLEMotilium
domperidone
Read the public record in its stated market, date and dosage-form context.
Read the archive and sources →Gastrointestinal · SOURCE-TRACEABLEGanaton / Elthon
itopride hydrochloride
Read the public record in its stated market, date and dosage-form context.
Read the archive and sources →LOOK · READ · ASK
See the pack, read the label, ask the right question
A practical path for families: capture identity clues, enlarge the label, organise the complete medicine list, then bring the key questions to a pharmacist or clinician.
Photo identification
Review a package or label photo locally. Record the name, strength, dosage form, lot and market before checking a primary source.
Open photo identification →Safety questions and larger-print label reading
The 400-question Chinese library is published. Question-by-question English translation and medical review continue; the English label-reading guide is available now.
Read the English label guide →Family medicine list
Record the name, ingredient, strength, dosage form and label wording from every pack. Entries stay on this device so a pharmacist can review possible duplicate ingredients or classes.
Open the local medicine list →Comparing medicines in the same class
Use labels, markets, dosage forms, price dates and study populations—not a pack photo or one number—to build a fair comparison.
Read the statin comparison framework →LEARN THE METHOD
Start with everyday label-reading questions
Begin with the numbers, dosage form and package in hand, then understand the boundaries of originator, generic and primary-source records.
SAFER MEDICINE READING
Reading a medicine label in larger print: mg, tablets, splitting, switching and combinations
Six practical questions make a small-print label easier to discuss: identify the exact product, understand what a strength means, check manipulation, prevent duplication and bring a complete medicine list to a pharmacist or prescriber.
2026-08-16 · Read article →DOSAGE FORMS & SAFETYInjections, oral medicines, patches and modified release: dosage form is identity
The same active ingredient does not necessarily mean the same medicine. Dosage form, route, strength, presentation and market are part of every comparison.
2026-08-14 · Read article →FOUNDATIONSOriginator and generic medicines: start with the right question
Do not turn “originator” and “generic” into a one-line ranking. Start with the exact active ingredient, form, market and current label, then read what each source can actually support.
2026-08-14 · Read article →EVIDENCE DESK
News belongs with the original publisher
SAFETY WATCH
Pharmacovigilance
Start with this record’s label, then check FDA, EMA, MHRA, PMDA and other official safety routes in the relevant market; a headline or report does not decide individual action.
Open safety watch →REGULATORY
Regulatory notices
FDA, EMA, WHO, NMPA, PMDA and peer authorities are the first verification route for product status and safety updates.
Browse regulators →JOURNALS
Journal reading
Original pages from Nature Portfolio, NEJM, The Lancet and JAMA help readers understand research; they do not replace regulatory labelling.
Browse publication sources →FOR ORGANIZATIONS · 机构服务
Need to bring medicine evidence into your product or service?
OriginDrug offers acceptance-ready bilingual medicine-evidence data, source-change maintenance and accessible-embedding assessment. Inspect the public samples first, then start a paid-pilot enquiry with five business facts.
Public records remain free. Commercial work cannot buy or alter public ranking, source standards or editorial conclusions.
Start by buyer scenario
- Health-tech and medicine-content teamsA 20-record data pilot.
Review the solution → - Pharmacy and patient-education teamsOlder-reader acceptance for one real page.
Review the solution → - Source-change monitoringA named medicine × market × source watchlist with dated change records.